Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis

Details for Australian Patent Application No. 2006299115 (hide)

Owner Berlin-Chemie AG

Inventors Schmitz, Reinhard; Wihsmann, Marc

Agent Lord and Company

Pub. Number AU-A-2006299115

PCT Pub. Number WO2007/039201

Priority 10 2005 046 769.5 29.09.05 DE

Filing date 27 September 2006

Wipo publication date 12 April 2007

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 31/7072 (2006.01)

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039201 Priority application(s): WO2007/039201

29 May 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 18 Apr 2008

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299126-Novel polymorphous form and the amorphous form of 5-chloro-N- ({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}- methyl)-2-thiophene carboxamide

2006299106-Compositions and methods for treating tumors presenting survivin antigens